23003
As part of the National Institute for Health and Clinical Excellence ( NICE ) single technology appraisal ( STA ) process , the manufacturer of golimumab ( Simponi ( (R) ) ; Merck Sharp & Dohme , USA ) was invited to submit evidence for its clinical and cost effectiveness for the treatment of rheumatoid arthritis ( RA ) after the failure of previous disease - modifying antirheumatic drugs ( DMARDs ) .
 None
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 None